Chen SL - Search Results

1

The N-terminal polypeptide derived from vMIP-II exerts its antitumor activity in human breast cancer through CXCR4/miR-7-5p/Skp2 pathway.

Wang HF, Dong ZY, Yan L, Yang S, Xu HN, Chen SL, Wang WR, Yang QL, Chen CJ. Wang HF, et al. Among authors: chen sl, chen cj. J Cell Physiol. 2020 Dec;235(12):9474-9486. doi: 10.1002/jcp.29755. Epub 2020 May 5. J Cell Physiol. 2020. PMID: 32372405

2

[Effect of mitochondrial DNA deletion on growth and invasiveness of human lymphoma Namalwa cells].

Ma J, Zhang Q, Chen C, Yang Q, Chen S. Ma J, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):188-92. Nan Fang Yi Ke Da Xue Xue Bao. 2013. PMID: 23443769 Chinese.

3

Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1α accumulation via increased production of reactive oxygen species.

Ma J, Zhang Q, Chen S, Fang B, Yang Q, Chen C, Miele L, Sarkar FH, Xia J, Wang Z. Ma J, et al. PLoS One. 2013 Jul 29;8(7):e69485. doi: 10.1371/journal.pone.0069485. Print 2013. PLoS One. 2013. Retraction in: PLoS One. 2018 Oct 2;13(10):e0205288. doi: 10.1371/journal.pone.0205288 PMID: 23922721 Free PMC article. Retracted.

4

Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway.

Wu Q, Wang R, Yang Q, Hou X, Chen S, Hou Y, Chen C, Yang Y, Miele L, Sarkar FH, Chen Y, Wang Z. Wu Q, et al. Oncotarget. 2013 Nov;4(11):1999-2009. doi: 10.18632/oncotarget.1471. Oncotarget. 2013. PMID: 24158561 Free PMC article.

5

Arsenic trioxide targets miR-125b in glioma cells.

Chen S, Zhu L, Huang J, Cai Y, Lu X, Yang Q, Wu Q, Chen C, Wang Z. Chen S, et al. Curr Pharm Des. 2014;20(33):5354-61. doi: 10.2174/1381612820666140128204132. Curr Pharm Des. 2014. PMID: 24479808

6

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.

Yang Q, Wang Y, Lu X, Zhao Z, Zhu L, Chen S, Wu Q, Chen C, Wang Z. Yang Q, et al. Oncotarget. 2015 Feb 20;6(5):3268-79. doi: 10.18632/oncotarget.3065. Oncotarget. 2015. PMID: 25605244 Free PMC article.

7

The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.

Wang R, Li Y, Hou Y, Yang Q, Chen S, Wang X, Wang Z, Yang Y, Chen C, Wang Z, Wu Q. Wang R, et al. Oncotarget. 2015 Mar 30;6(9):7000-10. doi: 10.18632/oncotarget.3193. Oncotarget. 2015. PMID: 25760076 Free PMC article.

8

[Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells].

Zhao ZL, Cai Y, Wang YY, Xia CL, Li CX, Chen SL, Yang QL, Chen CJ. Zhao ZL, et al. Among authors: chen sl, chen cj. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Jul;44(4):400-9. doi: 10.3785/j.issn.1008-9292.2015.07.09. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 26555418 Free PMC article. Chinese.

9

N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma.

Yang Q, Wu H, Wang H, Li Y, Zhang L, Zhu L, Wang W, Zhou J, Fu Y, Chen S, Wu Q, Chen C, Zhou C. Yang Q, et al. Int J Oncol. 2017 Apr;50(4):1160-1174. doi: 10.3892/ijo.2017.3906. Epub 2017 Mar 8. Int J Oncol. 2017. PMID: 28350074 Free PMC article.

10

The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism.

Yang QL, Zhang LY, Wang HF, Li Y, Wang YY, Chen TT, Dai MF, Wu HH, Chen SL, Wang WR, Wu Q, Chen CJ, Zhou CZ. Yang QL, et al. Among authors: chen tt, chen sl, chen cj. Oncotarget. 2017 Jun 6;8(23):37448-37463. doi: 10.18632/oncotarget.16394. Oncotarget. 2017. PMID: 28415580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,847 results

Search Page

Filters